Azar: 340B Reimbursement Cuts 'Transparency And Fairness' In Drug Pricing

By Michelle M. Stein / March 21, 2018 at 7:52 PM
A week after attacking drug-channel middle men, HHS Secretary Alex Azar touted cuts to hospitals' Medicare reimbursement for 340B drugs as an example of transparency and fairness in drug pricing at a community health centers conference on Friday (March 16). His remarks came day after Senate Democrats raised concerns with the cuts during a Senate health committee hearing. In the 2018 hospital outpatient pay rule, CMS cut hospitals' Medicare reimbursement for 340B drugs by 27 percent, and then-HHS Secretary Tom...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.